3.0.0
993
2025-12-05T09:09:06Z
2025-12-05T09:09:06Z
Senate
S
S
2023-03-28
118
https://www.congress.gov/bill/118th-congress/senate-bill/993
- ssbk00
Banking, Housing, and Urban Affairs Committee
Senate
Standing
  - Hearings By (full committee)
2024-01-11T15:00:00Z
- ssju00
Judiciary Committee
Senate
Standing
  - Referred To
2023-03-28T14:53:12Z

- Combating Illicit Xylazine Act
118
1839
HR
2023-04-07
Referred to the Subcommittee on Health.
  - Identical bill
CRS
- 2024-01-11
  - ssbk00
Banking, Housing, and Urban Affairs Committee
Senate
Committee on Banking, Housing, and Urban Affairs. Hearings held.
Committee
- 2023-03-28
  - ssju00
Judiciary Committee
Senate
Read twice and referred to the Committee on the Judiciary.
IntroReferral
- 2023-03-28
Introduced in Senate
IntroReferral
10000
9
Library of Congress
- C001113
Sen. Cortez Masto, Catherine [D-NV]
Catherine
Cortez Masto
D
NV
N
- G000386
Sen. Grassley, Chuck [R-IA]
Chuck
Grassley
R
IA
2023-03-28
True
- H001076
Sen. Hassan, Margaret Wood [D-NH]
Maggie
Hassan
D
NH
2023-03-28
True
- R000584
Sen. Risch, James E. [R-ID]
James
Risch
R
ID
E.
2023-03-28
True
- S001181
Sen. Shaheen, Jeanne [D-NH]
Jeanne
Shaheen
D
NH
2023-03-28
True
- C001047
Sen. Capito, Shelley Moore [R-WV]
Shelley
Capito
R
WV
Moore
2023-03-28
True
- M001198
Sen. Marshall, Roger [R-KS]
Roger
Marshall
R
KS
2023-03-28
True
- M001183
Sen. Manchin, Joe, III [D-WV]
Joseph
Manchin
D
WV
2023-03-28
True
- K000377
Sen. Kelly, Mark [D-AZ]
Mark
Kelly
D
AZ
2023-04-20
False
- R000605
Sen. Rounds, Mike [R-SD]
Mike
Rounds
R
SD
2023-05-04
False
- G000555
Sen. Gillibrand, Kirsten E. [D-NY]
Kirsten
Gillibrand
D
NY
E.
2023-05-04
False
- T000250
Sen. Thune, John [R-SD]
John
Thune
R
SD
2023-05-30
False
- H001079
Sen. Hyde-Smith, Cindy [R-MS]
Cindy
Hyde-Smith
R
MS
2023-06-01
False
- B000944
Sen. Brown, Sherrod [D-OH]
Sherrod
Brown
D
OH
2023-06-15
False
- S001217
Sen. Scott, Rick [R-FL]
Rick
Scott
R
FL
2023-06-15
False
- W000437
Sen. Wicker, Roger F. [R-MS]
Roger
Wicker
R
MS
F.
2023-07-11
False
- K000367
Sen. Klobuchar, Amy [D-MN]
Amy
Klobuchar
D
MN
2023-07-11
False
- R000595
Sen. Rubio, Marco [R-FL]
Marco
Rubio
R
FL
2023-07-11
False
- S000770
Sen. Stabenow, Debbie [D-MI]
Debbie
Stabenow
D
MI
2023-07-11
False
- Y000064
Sen. Young, Todd [R-IN]
Todd
Young
R
IN
2023-07-12
False
- R000608
Sen. Rosen, Jacky [D-NV]
Jacklyn
Rosen
D
NV
2023-07-12
False
- C001070
Sen. Casey, Robert P., Jr. [D-PA]
Bob
Casey
D
PA
2023-07-18
False
- B001319
Sen. Britt, Katie Boyd [R-AL]
Katie
Britt
R
AL
2023-07-18
False
- L000570
Sen. Lujan, Ben Ray [D-NM]
Ben
Luján
D
NM
R.
2023-07-20
False
- B001236
Sen. Boozman, John [R-AR]
John
Boozman
R
AR
2023-07-20
False
- V000137
Sen. Vance, J. D. [R-OH]
J.
Vance
R
OH
D.
2023-07-27
False
- K000384
Sen. Kaine, Tim [D-VA]
Timothy
Kaine
D
VA
M.
2023-07-27
False
- W000805
Sen. Warner, Mark R. [D-VA]
Mark
Warner
D
VA
R.
2023-09-05
False
- T000476
Sen. Tillis, Thomas [R-NC]
Thomas
Tillis
R
NC
Roland
2023-09-07
False
- B001277
Sen. Blumenthal, Richard [D-CT]
Richard
Blumenthal
D
CT
2023-09-26
False
- C000127
Sen. Cantwell, Maria [D-WA]
Maria
Cantwell
D
WA
2024-01-22
False
Crime and Law Enforcement
- Congressional oversight
2023-05-16T15:45:18Z
- Criminal procedure and sentencing
2023-05-16T15:45:18Z
- Drug trafficking and controlled substances
2023-05-16T15:45:18Z
- Manufacturing
2023-05-16T15:45:18Z
- Retail and wholesale trades
2023-05-16T15:45:18Z
- Veterinary medicine and animal diseases
2023-05-16T15:45:18Z
Crime and Law Enforcement
2023-04-12T16:00:23Z
00
2023-03-28
Introduced in Senate
2023-10-04T19:48:26Z
Combating Illicit Xylazine Act
This bill criminalizes the illicit use of xylazine. (Xylazine, also known as Tranq, is a sedative that is approved for use in animals. The Drug Enforcement Administration (DEA) has reported an increase in the trafficking of fentanyl mixed with xylazine.)
Specifically, the bill establishes criminal penalties for manufacturing, distributing, or dispensing, or possessing with intent to manufacture, distribute, or dispense, xylazine for illicit use (i.e., for use in humans) in accordance with the penalties for schedule III substances (up to 10 years imprisonment or, if death or serious bodily injury occurs, up to 15 years imprisonment, as well as criminal fines).
In addition, the DEA must coordinate with the Food and Drug Administration to report on the prevalence of the illicit use of xylazine, including associated supply chains. The bill also declares the illicit use of xylazine as an emerging drug threat.

Combating Illicit Xylazine Act
- Display Title
45

Combating Illicit Xylazine Act
2024-07-24T15:23:10Z
- Short Title(s) as Introduced
101

Combating Illicit Xylazine Act
2024-05-24T13:41:27Z
Introduced in Senate
IS
- Official Title as Introduced
6

A bill to prohibit certain uses of xylazine, and for other purposes.
2023-04-11T01:29:40Z
Introduced in Senate
IS
- Introduced in Senate
2023-03-28T04:00:00Z
  - https://www.govinfo.gov/content/pkg/BILLS-118s993is/xml/BILLS-118s993is.xml
2024-01-11
Committee on Banking, Housing, and Urban Affairs. Hearings held.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.